Nautilus Biotechnology, Inc.

2.87 USD
-0.07 (-2.38%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Nautilus Biotechnology, Inc. stock is down -3.69% since 30 days ago. The next earnings date is Feb 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 2 February’s closed higher than January.

About Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company was founded in 2016 and is headquartered in Seattle, Washington.